REGULATED PRESS RELEASE published on 10/31/2024 at 08:00, 1 year 10 months ago AMA : RAPPORT FINANCIER SEMESTRIEL 2024
REGULATED PRESS RELEASE published on 10/31/2024 at 08:00, 1 year 10 months ago AMA : Résultats du 1er semestre 2024 / Chiffre d’affaires du 3ème trimestre 2024 AMA annonce des résultats solides pour le 1er semestre 2024, avec une trésorerie nette de 6,8 M€ et une évolution vers l'offre technologique et commerciale. Détails des chiffres d'affaires et perspectives Résultats AMA Technologique Commercial 1er Semestre
REGULATED PRESS RELEASE published on 10/31/2024 at 08:00, 1 year 10 months ago AMA: 2024 half-year earnings / 2024 third-quarter revenues AMA Corporation PLC announces its 2024 half-year earnings and third-quarter revenues, showcasing a new strategic plan focusing on technological advancement and commercial offerings, with a net cash position of 6.8 million € Technological Advancement Strategic Plan AMA CORPORATION PLC Net Cash Position 2024 Half-year Earnings
BRIEF published on 07/26/2024 at 08:05, 2 years 1 month ago AMA: 2024 First-Half Earnings Artificial Intelligence Financial Strategy AMA Corporation 2024 Earnings Assisted Reality
BRIEF published on 07/26/2024 at 08:05, 2 years 1 month ago AMA : Chiffre d’affaires du 1er semestre 2024 Chiffre D'affaires Gouvernance Transformation Intelligence Artificielle AMA Corporation
REGULATED PRESS RELEASE published on 07/26/2024 at 08:00, 2 years 1 month ago AMA: 2024 first-half earnings AMA Corporation PLC announces 2024 first-half earnings with total sales of €1.3M, down 22%. Focus on AI-driven services for growth Strategic Plan Financial Update AMA Corporation 2024 Earnings AI Services
REGULATED PRESS RELEASE published on 07/26/2024 at 08:00, 2 years 1 month ago AMA : Chiffre d’affaires du 1er semestre 2024 AMA Corporation PLC publie son chiffre d'affaires consolidé pour le 1er semestre 2024 avec stratégies de croissance et situation financière renforcée Chiffre D'affaires AMA CORPORATION PLC Transformation Situation Financière Stratégies De Croissance
BRIEF published on 07/16/2024 at 08:05, 2 years 1 month ago AMA annonce la compatibilité de XpertEye avec Mistral XpertEye IA Productivité Mistral Compatibilité
BRIEF published on 07/16/2024 at 08:05, 2 years 1 month ago AMA Announces XpertEye Compatibility with Mistral Innovation AI Productivity XpertEye Compatibility
REGULATED PRESS RELEASE published on 07/16/2024 at 08:00, 2 years 1 month ago AMA annonce la compatibilité de XpertEye avec Mistral AMA annonce la compatibilité de XpertEye avec Mistral, renforçant son offre d'IA pour les professionnels de terrain. L'intégration avec Mistral complète les capacités existantes de la solution avec GPT-4o. Détails dans le communiqué de presse XpertEye IA AMA Mistral Professionnels De Terrain
Published on 09/11/2026 at 14:30, 23 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 55 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 1 hour 53 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 10 hours 53 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 16 hours 28 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/11/2026 at 14:35, 17 minutes ago EQS-Adhoc: Österreichische Post AG: AUSTRIAN POST REACHES AGREEMENT WITH THE REPUBLIC OF AUSTRIA TO PAY COMPENSATION FOR SOCIAL CONTRIBUTIONS RELATING TO CIVIL SERVANTS FOR THE YEARS 1996 TO 2008
Published on 09/11/2026 at 13:48, 1 hour 5 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 09/11/2026 at 07:00, 7 hours 53 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 7 hours 53 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 7 hours 53 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 19 hours 23 minutes ago Availability of the 2026 Interim Financial Report